Sarepta Therapeutics is a commercial-stage biopharmaceutical company headquartered in Cambridge, MA, specializing in precision genetic medicines for rare neuromuscular diseases. It leads in the discovery and development of targeted genetic therapies, addressing unmet medical needs in this specialized field. Sarepta's focused expertise positions it as an authority in rare disease biopharma.

‌